G6PD and malaria: For treatment of P. falciparum gametocytes, the World Health Organization (WHO) recommends that a 0.25 mg/kg single low dose of PQ (SLD-PQ) be used without G6PD testing, in conjunction with standard artemisinin-based combination therapy, in areas approaching malaria elimination and/or facing drug resistance [4, 5].